ReviewProteomics2026
Advancing Extracellular Vesicle Research: A Review of Systems Biology and Multiomics Perspectives.
Review in Proteomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Artificial intelligence virtual extracellular vesicles (AIVEVs).Bioactive materials · 2026Review
- Review
- Extracellular Vesicles as Biomarkers for Vascular Disease.Biomolecules · 2026Review
- Unlocking the power of extracellular vesicles: multi-omics integration for cancer biomarker discovery.Biomarker research · 2026Review
- Extracellular RNAs as Messengers and Early Biomarkers in Neurodegeneration.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Extracellular vesicles (EVs) are membrane-bound vesicles secreted by various cell types into the extracellular space and play a role in intercellular communication. Their molecular cargo varies depending on the cell of origin and its functional state. As a result, EVs serve as representatives of their parent cells and reservoirs of disease biomarkers. Their presence in diverse bodily fluids has fueled interest in their potential for biomarker discovery and signaling research. Advances in mass spectrometry, high-throughput sequencing, and bioinformatics have expanded the molecular characterization of EVs, while emerging tools, including artificial intelligence (AI), image-based systems biology, and curated EV repositories, are driving exploration of disease-associated molecular signatures. Omics technologies generate extensive, multidimensional datasets that can be analyzed using bioinformatics techniques in conjunction with traditional statistical methods. Systems-based approaches, such as network analysis, computer modeling, and AI, are particularly effective for interpreting these complex datasets. However, their application in EV studies requires a solid understanding of EV-specific biological principles and analytical tools to ensure accuracy. By leveraging these analytical strategies, systems biology aims to unravel the intricate organization of biological processes, providing insights into how EVs interact within cells and organisms, and how they can be utilized to advance disease diagnostics, monitor disease progression, and develop novel therapeutic strategies. This review aims to elucidate the state-of-the-art in EV research, integrating multiomics, modeling, and disease-specific insights. EV-specific data repositories and the future of EVs in systems biology will also be highlighted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.